Durability of Flexible Ureteroscopes and Causes of Infection During Flexible Ureterorenoscopy

Sponsor
Clinical Research Office of the Endourological Society (Other)
Overall Status
Completed
CT.gov ID
NCT03087812
Collaborator
(none)
400
1
24
16.7

Study Details

Study Description

Brief Summary

This is an observational study in which data on consecutive patients who undergo ureterorenoscopy with the use of a flexible ureterorenoscope are collected. In total 20 new ureteroscopes are usedfrom Olympus andfrom Storz) to study the durability of the ureteroscopes and the possible microbiological load.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This is an observational study in which data on consecutive patients who undergo ureterorenoscopy with the use of a flexible ureterorenoscope are collected. In total 6 new ureteroscopes are used (3 from Olympus and 3 from Storz) to study the durability of the ureteroscopes and the possible microbiological load.

    Before the procedure is started the endoscope is tested for its microbiological load in two different ways:1. Shake the tip of the flexible ureterorenoscope 5 seconds in a sterile container filled with 10 cc of NaCl 0.9% 2. Flush the working channel of the ureterorenoscope with 10 cc of NaCl 0.9% and collect the sample in a sterile container.

    After the procedure is finished, the endoscope is tested for its microbiological load in two different ways:

    1. Shake the tip of the flexible ureterorenoscope 5 seconds in a sterile container filled with 10 cc of NaCl 0.9% 2. Flush the working channel of the ureterorenoscope with 10 cc of NaCl 0.9% and collect the sample in a sterile container.

    Transfer all samples to the lab as soon as possible but at least within four hours after collecting the samples.

    As for the clinical efficacy during each procedure a detailed questionnaire about the use of each ureteroscope is filled out. This includes the ease of use making mention on quality of the image, torque, flexibility and durability.

    Data will be collected through electronic case report forms (eCFRs), with use of an online Data Management system (DMS).

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    400 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Durability of Flexible Ureteroscopes and Causes of Infection During Flexible Ureterorenoscopy
    Actual Study Start Date :
    Dec 1, 2015
    Actual Primary Completion Date :
    Dec 1, 2017
    Actual Study Completion Date :
    Dec 1, 2017

    Outcome Measures

    Primary Outcome Measures

    1. Microbiological load [2 years]

      To evaluate the pre-operative microbiological load of the tip and the working channel of the most common used flexible ureteroscopes, after high level disinfection

    Secondary Outcome Measures

    1. Durability [2 years]

      To evaluate the durability of the most common used flexible ureteroscopes in terms of number of procedures, total use time and total degrees of flexibility loss until the first repair is needed.

    2. Factors affecting durability [2 years]

      To evaluate descriptive data on factors that may affect the durability of the flexible ureteroscopes. Factors measured are treatment time, treatment indication and anatomical location in the urinary tract, method of ureteroscope insertion number and type of accessory instrumentation through the working channel, difference in users, number of forcing the scope during the procedure and the number of disinfections.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patient presented with a diagnosis to undergo a ureterorenoscopy using a flexible ureterorenoscope

    • over 18 years

    • has signed informed consent

    • the patient is being treated with the designated flexible ureterorenoscope

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 AMC University Hospital Amsterdam Netherlands 1105AZ

    Sponsors and Collaborators

    • Clinical Research Office of the Endourological Society

    Investigators

    • Study Chair: Jean de la Rosette, MD, PhD, Clinical Research Office of the Endourological Society

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Clinical Research Office of the Endourological Society
    ClinicalTrials.gov Identifier:
    NCT03087812
    Other Study ID Numbers:
    • NL201501
    First Posted:
    Mar 23, 2017
    Last Update Posted:
    Apr 10, 2018
    Last Verified:
    Apr 1, 2018
    Keywords provided by Clinical Research Office of the Endourological Society
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 10, 2018